Texas 2013 83rd Regular

Texas Senate Bill SB1542 Comm Sub / Bill

                    By: Van de Putte S.B. No. 1542
 (Zerwas)


 A BILL TO BE ENTITLED
 AN ACT
 relating to clinical initiatives to improve the quality of care and
 cost-effectiveness of the Medicaid program.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Subtitle I, Title 4, Government Code, is amended
 by adding Chapter 538 to read as follows:
 CHAPTER 538.  MEDICAID QUALITY IMPROVEMENT PROCESS FOR CLINICAL
 INITIATIVES
 SUBCHAPTER A.  GENERAL PROVISIONS
 Sec. 538.001.  DEFINITION. In this chapter, "Medicaid
 program" means the medical assistance program established under
 Chapter 32, Human Resources Code.
 Sec. 538.002.  EFFECT OF CHAPTER; AUTHORITY OF COMMISSION.
 This chapter does not affect or give the commission additional
 authority to:
 (1)  affect any individual health care treatment
 decision for a Medicaid recipient;
 (2)  replace or affect the process of determining
 Medicaid benefits, including the approval process for receiving
 benefits for durable medical equipment, or any applicable approval
 process required for reimbursement for services or other equipment
 under the Medicaid program;
 (3)  implement a clinical initiative or associated rule
 or program policy that is otherwise prohibited under state or
 federal law; or
 (4)  implement any initiative that would expand
 eligibility for benefits under the Medicaid program.
 Sec. 538.003.  RULES.  The executive commissioner shall
 adopt rules necessary to implement this chapter.
 SUBCHAPTER B.  MEDICAID QUALITY IMPROVEMENT PROCESS TO ASSESS
 CERTAIN CLINICAL INITIATIVES
 Sec. 538.051.  MEDICAID QUALITY IMPROVEMENT PROCESS. The
 commission shall, according to the provisions of this chapter,
 develop and implement a quality improvement process by which the
 commission:
 (1)  receives suggestions for clinical initiatives
 designed to improve:
 (A)  the quality of care provided under the
 Medicaid program; and
 (B)  the cost-effectiveness of the Medicaid
 program;
 (2)  conducts a preliminary review under Section
 538.053(4) of each suggestion received under Section 538.052 to
 determine whether the suggestion warrants further consideration
 and analysis; and
 (3)  conducts an analysis under Section 538.054 of
 clinical initiative suggestions that are selected for analysis
 under Subdivision (2) and of required clinical initiatives under
 Section 538.0521.
 Sec. 538.052.  SOLICITATION OF SUGGESTIONS FOR CLINICAL
 INITIATIVES. (a)  Subject to Subsection (b), the commission shall
 solicit and accept suggestions for clinical initiatives, in either
 written or electronic form, from:
 (1)  a member of the state legislature;
 (2)  the executive commissioner;
 (3)  the commissioner of the Department of Aging and
 Disability Services;
 (4)  the commissioner of the Department of State Health
 Services;
 (5)  the commissioner of the Department of Family and
 Protective Services;
 (6)  the commissioner of the Department of Assistive
 and Rehabilitative Services;
 (7)  the medical care advisory committee established
 under Section 32.022, Human Resources Code;
 (8)  the physician payment advisory committee created
 under Section 32.022(d), Human Resources Code; and
 (9)  the Electronic Health Information Exchange System
 Advisory Committee established under Section 531.904.
 (b)  The commission may not accept suggestions under this
 section for an initiative that:
 (1)  is undergoing clinical trials; or
 (2)  expands a health care provider's scope of practice
 beyond the law governing the provider's practice.
 Sec. 538.0521.  REQUIRED CLINICAL INITIATIVES.  (a)  In
 addition to the clinical initiatives selected for analysis under
 Section 538.054, the commission shall conduct an analysis and issue
 a final report in accordance with the requirements of this chapter
 for the following:
 (1)  an initiative that would require hospitals to
 implement evidence-based protocols, including early goal-directed
 therapy, in the treatment of severe sepsis and septicemia; and
 (2)  an initiative that would authorize the Medicaid
 program to provide blood-based allergy testing for patients with
 persistent asthma to develop an appropriate treatment strategy that
 would minimize exposure to allergy-induced asthma attacks.
 (b)  This section expires August 31, 2014.
 Sec. 538.053.  CLINICAL INITIATIVE EVALUATION PROCESS.  The
 commission shall establish and implement an evaluation process for
 the submission, preliminary review, analysis, and approval of a
 clinical initiative.  The process must:
 (1)  require that a suggestion for a clinical
 initiative be submitted to the state Medicaid director;
 (2)  require that a suggestion for a clinical
 initiative selected for analysis under Section 538.054 be published
 on the Internet website created under Section 538.056 not later
 than the 30th day after the date on which the state Medicaid
 director receives the suggestion;
 (3)  provide for a formal public comment period that
 lasts at least 30 days during which the public may submit comments
 and research relating to a suggested clinical initiative;
 (4)  allow the commission to conduct with the
 assistance of appropriate advisory committees or similar groups as
 determined by the commission a preliminary review of each suggested
 clinical initiative to determine whether the initiative warrants
 further consideration and analysis under Section 538.054;
 (5)  limit the number of suggestions that receive
 analysis under Section 538.054;
 (6)  require the commission to publish on the Internet
 website created under Section 538.056 the criteria the commission
 uses in the preliminary review under Subdivision (4) to determine
 whether an initiative warrants analysis under Section 538.054;
 (7)  require commission employees to perform an
 analysis of each suggested clinical initiative selected for
 analysis in accordance with Section 538.054; and
 (8)  require the development and publication of a final
 report in accordance with Section 538.055 on each clinical
 initiative selected for analysis under Section 538.054 not later
 than the 180th day after the date on which the state Medicaid
 director receives the suggestion.
 Sec. 538.054.  ANALYSIS OF CLINICAL INITIATIVES. The
 commission shall conduct an analysis of each clinical initiative
 selected by the commission after having conducted the commission's
 preliminary review under Section 538.053(4).  The analysis required
 under this section must include a review of:
 (1)  any public comments and submitted research
 relating to the initiative;
 (2)  the available clinical research and historical
 utilization information relating to the initiative;
 (3)  published medical literature relating to the
 initiative;
 (4)  any adoption of the initiative by medical
 societies or other clinical groups;
 (5)  whether the initiative has been implemented under:
 (A)  the Medicare program;
 (B)  another state medical assistance program; or
 (C)  a state-operated health care program,
 including the child health plan program;
 (6)  the results of reports, research, pilot programs,
 or clinical studies relating to the initiative conducted by:
 (A)  institutions of higher education, including
 related medical schools;
 (B)  governmental entities and agencies; and
 (C)  private and nonprofit think tanks and
 research groups;
 (7)  the impact that the initiative would have on the
 Medicaid program if implemented in this state, including:
 (A)  an estimate of the number of recipients under
 the Medicaid program that would be impacted by implementation of
 the initiative; and
 (B)  a description of any potential cost savings
 to the state that would result from implementation of the
 initiative; and
 (8)  any statutory barriers to implementation of the
 initiative.
 Sec. 538.055.  FINAL REPORT ON CLINICAL INITIATIVE. The
 commission shall prepare a final report based on the commission's
 analysis of a clinical initiative under Section 538.054.  The final
 report must include:
 (1)  a final determination of:
 (A)  the feasibility of implementing the
 initiative;
 (B)  the likely impact implementing the
 initiative would have on the quality of care provided under the
 Medicaid program; and
 (C)  the anticipated cost savings to the state
 that would result from implementing the initiative;
 (2)  a summary of the public comments, including a
 description of any opposition to the initiative;
 (3)  an identification of any statutory barriers to
 implementation of the initiative; and
 (4)  if the initiative is not implemented, an
 explanation of the decision not to implement the initiative.
 Sec. 538.056.  INTERNET WEBSITE. The commission shall
 maintain an Internet website related to the quality improvement
 process required under this chapter.  The website must include:
 (1)  an explanation of the process for submission,
 preliminary review, analysis, and approval of clinical initiatives
 under this chapter;
 (2)  an explanation of how members of the public may
 submit comments or research related to an initiative;
 (3)  a copy of each initiative selected for analysis
 under Section 538.054;
 (4)  the status of each initiative in the approval
 process; and
 (5)  a copy of each final report prepared under this
 chapter.
 Sec. 538.057.  ACTION ON CLINICAL INITIATIVE BY COMMISSION.
 After the commission conducts an analysis of a clinical initiative
 under Section 538.054:
 (1)  if the commission has determined that the
 initiative is cost-effective and will improve the quality of care
 under the Medicaid program, the commission may:
 (A)  implement the initiative if implementation
 of the initiative is not otherwise prohibited by law; or
 (B)  if implementation requires a change in law,
 submit a copy of the final report together with recommendations
 relating to the initiative's implementation to the standing
 committees of the senate and house of representatives having
 jurisdiction over the Medicaid program; and
 (2)  if the commission has determined that the
 initiative is not cost-effective or will not improve quality of
 care under the Medicaid program, the commission may not implement
 the initiative.
 SECTION 2.  Not later than January 1, 2014, the Health and
 Human Services Commission shall conduct an analysis and submit a
 final report on the clinical initiatives required under Section
 538.0521, Government Code, as added by this Act.
 SECTION 3.  If before implementing any provision of this Act
 a state agency determines that a waiver or authorization from a
 federal agency is necessary for implementation of that provision,
 the agency affected by the provision shall request the waiver or
 authorization and may delay implementing that provision until the
 waiver or authorization is granted.
 SECTION 4.  This Act takes effect immediately if it receives
 a vote of two-thirds of all the members elected to each house, as
 provided by Section 39, Article III, Texas Constitution.  If this
 Act does not receive the vote necessary for immediate effect, this
 Act takes effect September 1, 2013.